| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |